Results 31 to 40 of about 2,113,927 (314)

STrengthening the Reporting of OBservational studies in Epidemiology--Molecular Epidemiology STROBE-ME: an extension of the STROBE statement. [PDF]

, 2011
Advances in laboratory techniques have led to a rapidly increasing use of biomarkers in epidemiological studies. Biomarkers of internal dose, early biological change susceptibility and clinical outcomes are used as proxies for investigating the ...
David H. Phillips, Schoket, B, Peter B Farmer, Dep IRAS, G. Matullo (7601792), Vermeulen Roel, Giuseppe Matullo, Valentina Gallo, Kirsch-Volders, Micheline, B. Schoket (7601798), Porta Miquel, Kirsch-Volders, M, R. Vermeulen, Miquel Porta, Wild Christopher, Egger, M, Phillips, David, Gallo Valentina, Egger, M., Phillips, D.H., Phillips, DH, Vineis, P., Farmer, P.B., Porta, M, John P.A. Ioannidis, John P. A. Ioannidis, C. Wild, McCormack Valerie, Porta, Miquel, Porta, M., U. Stromberg (7601801), Lund University., M. Egger, Roel Vermeulen, Stromberg, U., Ioannidis, John P. A., Matullo, Giuseppe, Farmer, Peter B, P. Vineis (7601795), David H Phillips, Christopher Wild, McCormack, Valerie, Schoket Bernadette, B. Schoket, Farmer, PB, John P A Ioannidis, G. Matullo, Stromberg, U, Ioannidis, JP, Wild, C., Farmer, Peter B., Ulf Stromberg, Valerie McCormack, Matullo Giuseppe, V. Gallo (7601771), Vineis, Paolo, Loannidis, John P. A., D. H. Phillips (2298805), Gallo, Valentina, V. Mccormack (7601777), Wild, Christopher, V. Gallo, U. Stromberg, STROBE Statement, J. P. A. Ioannidis (7601786), M. Egger (7601774), P. B. Farmer, Matthias Egger, C. Wild (7601780), Schoket, B., V. McCormack, Strömberg, Ulf,, Gallo, V., P. Vineis, Gallo, V, Phillips, David H., Peter B. Farmer, Wild, C, Kirsch-Volders, M., R. Vermeulen (3788842), Phillips, David H, ?, ?, Stromberg, Ulf, McCormack, V., Phillips David H., M. Porta (7601804), Farmer Peter B., Ioannidis John P. A., M. Kirsch-Volders, Bernadette Schoket, Egger, Matthias, Egger Matthias, Ioannidis, John P A, McCormack, V, Vermeulen, Roel, Risk Assessment of Toxic and Immunomodulatory Agents, D. H. Phillips, Ioannidis, J.P., M. Porta, Matullo, G, Stromberg Ulf, Vineis Paolo, Vermeulen, R., Ioannidis, John PA, J. P. A. Ioannidis, M. Kirsch-Volders (7601789), Schoket, Bernadette, Matullo, G., P. B. Farmer (7601783), Vineis, P, STROBE Statement,, Kirsch-Volders Micheline, Micheline Kirsch-Volders, Porta, Miguel, Paolo Vineis, Vermeulen, R   +115 more
core   +12 more sources

Biomarkers of Pineal Region Tumors: A Review [PDF]

Ochsner Journal, 2019
Background: The pineal gland, a small, pinecone-shaped organ deep within the brain, is responsible for producing melatonin. The gland consists of pineal parenchymal cells and glial cells that can form neoplasms. Pineal region neoplasms can also arise from germ cells and adjacent structures.
Carr, Christopher, O'Neill, Brannan E., Hochhalter, Christian B., Strong, Michael J., Ware, Marcus L.   +4 more
openaire   +5 more sources

Serum-Exosome-Derived miRNAs Serve as Promising Biomarkers for HCC Diagnosis

, 2022
Background: Serum exosomes are emerging as key liquid biopsy biomarkers for the early diagnosis of cancer. However, the proportion and distribution of small RNA (sRNA) species from serum exosomes of hepatocellular carcinoma (HCC) patients remain unclear.
Ning Tang, Tao Rui, Jufeng Guo, Zonglei Mao, Xiaobing Zhang, Jian Liu, Aizhai Xiang   +6 more
core   +1 more source

Probabilistic independent component analysis of dynamic susceptibility contrast perfusion MRI in metastatic brain tumors

Cancer Imaging, 2019
Purpose To identify clinically relevant magnetic resonance imaging (MRI) features of different types of metastatic brain lesions, including standard anatomical, diffusion weighted imaging (DWI) and dynamic susceptibility contrast (DSC) perfusion MRI ...
Ararat Chakhoyan, Catalina Raymond, Jason Chen, Jodi Goldman, Jingwen Yao, Tania B. Kaprealian, Nader Pouratian, Benjamin M. Ellingson   +7 more
doaj   +1 more source

Cell surface membrane proteins as personalized biomarkers: where we stand and where we are headed [PDF]

, 2013
Personalized medicine requires the development of a wide array of biomarker diagnostic assays, reflecting individual variations and thus allowing tailored therapeutic interventions.
Szabó, Edit, Sarkadi, Balázs, Várady, György, Németh, Adrienn, Cserepes, Judit   +4 more
core   +1 more source

The Korean Society for Neuro-Oncology (KSNO) guideline for antiepileptic drug usage of brain tumor: Version 2021.1 [PDF]

, 2021
Background: To date, there has been no practical guidelines for the prescription of antiepileptic drugs (AEDs) in brain tumor patients in Korea. Thus, the Korean Society for Neuro-Oncology (KSNO), a multidisciplinary academic society, had begun preparing
김세훈, 윤홍인, 장종희
core   +1 more source

Tumor Mutational Burden as a Predictive Biomarker in Solid Tumors [PDF]

Cancer Discovery, 2020
Abstract Tumor mutational burden (TMB), defined as the number of somatic mutations per megabase of interrogated genomic sequence, varies across malignancies. Panel sequencing–based estimates of TMB have largely replaced whole-exome sequencing–derived TMB in the clinic.
Dan Sha, Zhaohui Jin, Jan Budczies, Klaus Kluck, Albrecht Stenzinger, Frank A. Sinicrope   +5 more
openaire   +2 more sources

The Current Landscape of Glioblastoma Biomarkers in Body Fluids

, 2023
Glioblastoma (GBM) is a highly aggressive and lethal primary brain cancer that necessitates early detection and accurate diagnosis for effective treatment and improved patient outcomes.
Mohammad Doroudian, Fatemeh Farjadian, Soumya Rahima Benhabbour, Nazanin Esmaelizad, Elham Abbasgholinejad, Saba Zanganeh   +5 more
core   +1 more source

Plasma IgG and IgM autoantibodies to COPT1 as potential biomarkers for detection of non-small cell lung cancer

Frontiers in Immunology
BackgroundEarly diagnosis of lung cancer is crucial for improving patient outcomes. Autoantibodies against tumor-associated antigens (TAAs) found in the plasma can serve as biomarkers for lung cancer detection.
Xiaobin Cao, Xiaobin Cao, Jing Li, Siyu Liu, Siyu Liu, Aichen Liu, Lulu Zhang, Fengqi Chen, Yutong Li, Yutong Li, Hanke Ma, Wenke Sun, Songyun Ouyang, Liping Dai, Jingjing Liu   +14 more
doaj   +1 more source

Phospholipids profiling and outcome of peritoneal dialysis patients

, 2014
Objectives: To investigate phospholipids (PLs) biomarkers in predicting outcome of patients undergoing peritoneal dialysis (PD). Materials and methods: Twenty PD patients were followed using baseline plasma PLs with an improved online two-dimensional ...
Li, Min, Tang, Wen, Lu, Xin-Hong, Wang, Tao, Liu, Hu-Wei   +4 more
core   +1 more source